Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Stents are medical devices intended for the treatment of blocked vascular paths. The procedure used to reduce blockages is known as percutaneous transluminal coronary angioplasty (PTCA). Stents used for arterial blockage are called coronary stents or heart stents. These stents are also used to prevent re-narrowing of the arteries. Coronary stents can be of three types; bare metal stents, drug eluting stents, and bioabsorbable stents. Although, bare metal stents dramatically improve angiographic and clinical outcomes of patients, the rate of restenosis is 20–30%. This is a major factor limiting the usage of bare metal stents and development of next generation of drug eluting stents.

The global coronary stents market is estimated to be valued at US$ 8,985.6 million in 2020 and is expected to exhibit a CAGR of 7.7% during the forecast period (2020-2027).

Figure 1. Global Coronary Stents Market Share (%) in Terms of Value, By Region, 2020

Coronary Stents  | Coherent Market Insights

The increasing prevalence of coronary heart disease is expected to drive the market growth during the forecast period

Coronary heart disease (CHD) is usually caused by a build-up of fatty deposits (atheroma) on the walls of the arteries around the heart (coronary arteries). The build-up of atheroma makes the arteries narrower, restricting the flow of blood to the heart muscle. This process is called atherosclerosis. Thus, the rising prevalence of coronary heart disease is increasing demand for coronary stents for management of coronary heart diseases.

According to the World Health Organization’s 2017 report, cardiovascular diseases (CVDs) were the number 1 cause of death globally, and around 17.9 million individuals died due to cardiovascular diseases in 2016. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions.

Moreover, according to the U.S. Department of Health & Human Services report, coronary heart disease is the most common type of heart disease in the U.S. In 2017, around 3,65,914 people died due to coronary heart disease in the U.S.

Figure 2. Global Coronary Stents Market Share (%), by Product Type, 2020

Coronary Stents  | Coherent Market Insights

Launch and approval of novel products is expected to drive the market growth during the forecast period

Key players operating in the global coronary stents market are focusing on product launches and obtaining regulatory approval for novel coronary stents which is expected to drive the market growth during the forecast period

For instance, in February 2019, Medtronic PLC received an approval from the U.S. Food and Drug Administration for its Resolute Drug-Eluting Stent (DES) platform (including the Resolute Onyx and Resolute Integrity DES) for treatment of patients with coronary artery disease who have de novo chronic total occlusion (CTO), a complex vessel condition of complete blockage of a coronary artery. CTO is considered more difficult to treat with percutaneous coronary intervention (PCI) due to a greater risk of complications.

request-sample

Coronary Stents Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 8,985.6 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 7.7% 2027 Value Projection: US$ 15,109.2 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Bare-Metal Stents, Drug Eluting Stents, Bioabsorbable Stents.
  • By Material
    • Metallic: Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, Others.
    • Polymeric: Non-degradable / Permanent Stents, Degradable / Temporary Stents.
  • By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers.
Companies covered:

Boston Scientific Corporation, Abbott, Medtronic Plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA

Growth Drivers:
  • The increasing prevalence of coronary heart disease
  • Launch and approval of novel products
Restraints & Challenges:
  • Risky stent implantation
  • Complications associated with implantation of stents

In September 2019, OrbusNeich Medical K.K., a Japan-based company, received approval for its COMBO Plus Coronary Stent from the Japan Ministry of Health, Labor, and Welfare (MHLW). The COMBO Plus Coronary Stent is the first drug-eluting stent [DES] to combine the proprietary endothelial progenitor cell [EPC] capture technology with an abluminal sirolimus drug elution delivered from a biodegradable matrix polymer that achieves full and complete dissipation in 90 days.

Moreover, in May 2019, Medtronic Plc launched the Telescope Guide Extension Catheter. The extension catheters help to deliver coronary stents, balloons and other interventional devices during angioplasty procedures that help to restore blood flow through the coronary and peripheral arteries.

Global Coronary Stents Market – Impact of Coronavirus (Covid-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries around the globe with the World Health Organization declaring it a public health emergency. According to the World Health Organization’s report, the manifestation of COVID-19 has resulted in more than 20.6 million infected individuals worldwide as of 13 August 13, 2020. Furthermore, the global COVID-19 pandemic has led to a sudden pause in manufacturing activities across the globe, thereby affecting demand for coronary stents, as well as production and processing of coronary stents.

Global Coronary Stents Market Restraint

Factors such as risky stent implantation and complications associated with implantation of stents is expected to negatively affect growth of the market. For instance, stents implantation is prone to stents displacement and re-narrowing of the arteries. Re-blockages are addressed by administering blood-thinning drugs, which is leading to high adoption of drug eluting coronary stents.

Key Players

Major players operating in the global medical metal tubing market are Boston Scientific Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA

Coronary stents are small interventional devices used for opening blocked arteries and preventing re-narrowing of arteries. The global coronary stents market report provide a valuable tool for evaluation of coronary stents in the current scenario and trends during the forecast period (2020-2027). The report delivers in depth analysis of factors driving as well as restraining the market growth and also enlightens further market opportunity for manufacturers. The report also covers key developments and company strategies to expand the market share.

Market Dynamics

Product launches coupled with increasing geographical expansion of drug-eluting coronary stents product portfolio is propelling growth of the coronary stents market over the forecast period. For instance, in May 2018, Abbott received the U.S. FDA approval for XIENCE Sierra, the new generation of everolimus-eluting coronary stent. The XIENCE received approval from Japan’s regulatory body in April 2018, and CE mark from European regulatory bodies in 2017. Furthermore, companies are also evaluating and launching products using novel material, such as metal like cobalt chromium and fully biodegradable stents. For instance, in 2017, Biotronik received U.S. Food and Drug Administration approval for PRO-Kinetic energy cobalt chromium-based bare metal coronary stent system to treat coronary artery blockage. However, the coronary stents market growth is subject to stringent regulatory approval policies for interventional devices and medical complications such as restenosis and thrombosis, which is expected to restrain the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global coronary stents market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global coronary stents market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Boston Scientific Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, type up-gradation, market expansion, and marketing tactics
  • The global coronary stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronary stents market.

Detailed Segmentation:

  • Global Coronary Stents Market, By Product Type:
    • Bare-Metal Stents
    • Drug Eluting Stents
    • Bioabsorbable Stents
  • Global Coronary Stents Market, By Material:
    • Metallic
      • Stainless Steel
      • Silicon Carbide
      • Titanium Nitride Oxide
      • Cobalt Chromium
      • Platinum Chromium
      • Others
    • Polymeric
      • Non-degradable/Permanent Stents
      • Degradable/Temporary Stents
  • Global Coronary Stents Market, By End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
  • Global Coronary Stents Market, By Region:
    • North America
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable/Permanent Stents
          • Degradable/Temporary Stents
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable/Permanent Stents
          • Degradable/Temporary Stents
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable/Permanent Stents
          • Degradable/Temporary Stents
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable/Permanent Stents
          • Degradable/Temporary Stents
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable/Permanent Stents
          • Degradable/Temporary Stents
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable/Permanent Stents
          • Degradable/Temporary Stents
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Boston Scientific Corporation*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Abbott
    • Medtronic Plc
    • Braun Melsungen AG
    • Stentsy SA
    • Terumo Interventional Systems
    • Kyoto Medical Planning Co., Ltd.
    • QualiMed
    • Elixir Medical Corporation
    • ENDOCOR GmbH
    • BIOTRONIK SE & Co. KG
    • Amaranth Medical, Inc.
    • Arterial Remodeling Technologies SA

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Material
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Highlights
    • Regulatory Scenario
    • Reimbursement Scenario
    • PEST Analysis
    • Porter’s Analysis
    • Mergers and Acquisition
    • Technological Advancement
    • Product Launches/Approvals
    • Epidemiology
  4. Global Coronary Stents Market – Impact of Coronavirus (COVID-19) Pandemic
    • Impact assessment
    • Supply Chain Analysis
    • Government measures to combat COVID-19
  5. Global Coronary Stents Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Bare-Metal Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug Eluting Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Bioabsorbable Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Coronary Stents Market, By Material, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Metallic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Stainless Steel
        • Silicon Carbide
        • Titanium Nitride Oxide
        • Cobalt Chromium
        • Platinum Chromium
        • Others
    • Polymeric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Non-degradable/Permanent Stents
        • Degradable/Temporary Stents
  7. Global Coronary Stents Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Coronary Stents Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Material, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Material, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Material, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Material, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Material, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Material, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Boston Scientific Corporation*
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic Plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Stentsy SA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Interventional Systems
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Kyoto Medical Planning Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • QualiMed
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Elixir Medical Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ENDOCOR GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BIOTRONIK SE & Co. KG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Amaranth Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Arterial Remodeling Technologies SA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 41 market data tables and 30 figures on "Coronary Stents Market” - Global forecast to 2027

Frequently Asked Questions

The global coronary stents market size is estimated to be valued at US$ 8,985.6 million in 2020 and is expected to exhibit a CAGR of 7.7% between 2020 and 2027.
The increasing prevalence of coronary heart disease, launch and approval of novel products, and collaborations and acquisitions by key players is expected to drive the market growth during the forecast period.
Polymeric material segment is expected to hold the major market share, owing to an increasing number of product approvals and launches during the forecast period.
North America medical coronary stents market is expected to generate highest revenue share during the forecast period.
Major factors hampering growth of the market are risky stent implantation and complications associated with implantation of stents.
Major players operating in the global coronary stents market are Boston Scientific Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner